Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease.
about
Behavioral and psychological symptoms of dementiaNonpharmacologic management of behavioral symptoms in dementiaExamining the Pathways Between Self-Awareness and Well-Being in Mild to Moderate Alzheimer Disease.Factors associated with caregiver burden in patients with Alzheimer's disease.Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol.Correlates of quality of life for individuals with dementia living at home: the role of home environment, caregiver, and patient-related characteristicsGender-dependence of substituted judgment on quality of life in patients with dementia.The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA StudyDepression in elderly patients with Alzheimer dementia or vascular dementia and its influence on their quality of life.Depressive symptoms are associated with analgesic use in people with Alzheimer's disease: Kuopio ALSOVA study.Potential Antidepressant Role of Neurotransmitter CART: Implications for Mental DisordersTotal testosterone and neuropsychiatric symptoms in elderly men with Alzheimer's diseaseAssessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study.Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model.Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia.Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.Reduced quality-of-life ratings in mild cognitive impairment: analyses of subject and informant responsesManagement of patients with Alzheimer's disease: pharmacological treatment and quality of lifeNeuropsychiatric Symptoms in Posterior Cortical Atrophy and Alzheimer Disease.Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's diseaseSubscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.Depression in cognitive impairment.Assessing quality of life in Alzheimer's disease: Implications for clinical trials.Effects of Self-Management Groups for People with Dementia and Their Spouses--Randomized Controlled Trial.Vascular factors are associated with the severity of the neuropsychiatric symptoms in Alzheimer's disease.Efficacy of Ginkgo biloba extract EGb 761(®) in dementia with behavioural and psychological symptoms: A systematic review.Factors associated with the quality of life of people with dementia and with quality of life-improving interventions: Scoping review.Associations Across Caregiver and Care Recipient Symptoms: Self-Organizing Map and Meta-analysis.Neuropsychiatric symptoms in people screened positive for dementia in primary care.Decreasing sense of coherence and its determinants in spousal caregivers of persons with mild Alzheimer's disease in three year follow-up: ALSOVA study.Self-Perceived Quality of Life Among Patients with Alzheimer's Disease: Two Longitudinal Models of Analysis.Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.Early psychosocial intervention does not delay institutionalization in persons with mild Alzheimer disease and has impact on neither disease progression nor caregivers' well-being: ALSOVA 3-year follow-up.Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer's disease: a 24-month follow-up study.The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia PopulationsDifferentiating subtypes of apathy to improve person-centered care in frontotemporal degeneration.Factors associated with caregivers' underestimation of quality of life in patients with Alzheimer's disease.Donepezil abolishes anticholinergic activity in a patient with amnesia.Neuropsychiatric Symptoms in Patients With Alzheimer's Disease: The Role of Caregiver Burden and Coping Strategies.
P2860
Q21129432-3CF573D9-1454-4AFD-A849-E9BA496A205EQ24598981-0183270F-92E2-4BC2-B50B-98A2B1A03E0AQ30679891-91995E87-85EE-4943-843D-B9D027F5A966Q33620363-297575DB-498F-4377-9855-066C1BD7B9CAQ33795585-32077AF1-024D-4ECA-8555-9DC5CF543474Q33880678-638473AA-3752-424F-A669-24772E03D68AQ34035954-B1385406-DA85-4DFF-A0BB-CE3DE8711478Q34975011-26A46ACA-F31A-4F7B-97F7-B9D447CFA76DQ35067536-D845F565-CBDC-4E03-A57F-DD71515E076FQ35092449-E5A3CDF3-D3AA-4ADA-A33B-DF4E87A234BBQ35110380-9DB70DD7-6EE2-4E00-8E49-9DD78726D4DBQ35559314-EE37EFF2-53CD-454E-9874-F2887EF7AC84Q35619443-C34264BB-CBF5-4304-ACB7-92A3B3F3B25CQ36047779-FB4478E3-416F-4B17-B556-B45BD18E0589Q36209842-B01F38C4-8FFF-4A91-81B0-34BE0618EE38Q36255612-A728F79F-7B61-413F-806E-3ACA086ED9D0Q36385255-183AE564-5F13-4620-89B7-0D38EC1A2CDFQ36441806-8FD66016-412A-44AC-A531-4B9AB34D2C6BQ36515587-AC77A566-43A1-4244-B97B-C3768A870910Q36565890-838A5577-865A-41FD-A187-7E21784DF85FQ36780771-A4FE879A-D793-4ECD-AC76-3B6F7FCB2BE1Q37555160-D3E42BD3-17FB-4051-857C-38D0867E5E8EQ37608839-7AC8336F-F4A1-4986-A00B-AC9137548DAAQ37645462-7492B921-C2FA-4C2B-A432-B200DCEE563DQ38393835-0D54A5FE-714C-44AD-95A7-3B503AA5C94BQ38445193-2EF83D1E-E2AD-4B05-AB43-48A9227A75D1Q38557137-E80530BC-E4F2-4155-B070-835B9058D457Q38657177-15C43973-1609-4A4C-9816-9B37E9712544Q38885944-B061F71C-E709-47E3-8727-64A18E0128E9Q39124692-A805111E-F31C-474A-9312-B686E854DD20Q39225713-01845E9D-77A5-4E7B-9638-33D01BB83143Q39850165-1BB9A56C-B2DA-47FA-8B6B-95E2485515C2Q40457921-A6BE7979-78A0-4696-A217-45317EEF0A6AQ40733328-F24411CD-DAC0-4A4F-9C76-0BDD1E925CA9Q40950974-115D0209-B273-4434-9F2D-66A087AE1561Q42381174-3F6182DE-329C-4345-864D-A1DE4398F6B3Q43087254-9F6C1941-8B3C-480C-BDA0-9546DB95A8DAQ43413978-07960BF4-4F13-4D87-9DF8-513C0628B52CQ45789315-8BE24AA8-B179-436D-8C4D-F633DA056C1CQ45857521-4F05B24E-3220-4166-9164-7F74C9315EF7
P2860
Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Neuropsychiatric symptoms and ...... and mild Alzheimer's disease.
@en
Neuropsychiatric symptoms and ...... and mild Alzheimer's disease.
@nl
type
label
Neuropsychiatric symptoms and ...... and mild Alzheimer's disease.
@en
Neuropsychiatric symptoms and ...... and mild Alzheimer's disease.
@nl
prefLabel
Neuropsychiatric symptoms and ...... and mild Alzheimer's disease.
@en
Neuropsychiatric symptoms and ...... and mild Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
Neuropsychiatric symptoms and ...... and mild Alzheimer's disease.
@en
P2093
ALSOVA study group
Asta Hiltunen
Hannu Valtonen
Jaana Suhonen
Janne Martikainen
Juhani Sivenius
Kristiina Karttunen
Matti Vanhanen
Pertti Karppi
Tarja Välimäki
P2860
P304
P356
10.1002/GPS.2550
P407
P577
2010-10-29T00:00:00Z